Aetion is pleased to announce the appointment of Priya Bhargava as Chief Product Officer. She is the newest leader to join Aetion, reinforcing the Company's commitment to accelerating and advancing RWE technology globally.
Priya brings more than 20 years of critical experience in the health and technology industries, d
eveloping and commercializing analytical products at companies such as Shyft Analytics, Medidata, and, most recently, Cytel where she served as General Manager of Software and Chief Product Officer. Holding degrees in biology, epidemiology, and entrepreneurship,
Priya brings an incredible blend of education and aptitude to Aetion, and will use her experience to oversee the advancement of the
Aetion Evidence Platform®
.
“
Aetion is currently center-stage in real-world evidence with a global team dedicated to developing cutting-edge analytic solutions,” Priya said. “Our job is to intimately understand our customer challenges. We can leverage design, data science, and technology to anticipate our customers’ most critical questions and deliver innovative, ready-built product solutions.”
Priya joins Aetion during a sustained period of momentum following the acquisition of the synthetic data firm
Replica Analytics
, and recent partnership announcements with the
National Evaluation System for health Technology Coordinating Center
(NESTcc) and
Cognito Therapeutics
.
“Our ability to meaningfully and efficiently respond to our customers’ biggest challenges depends greatly on our technology’s capacity to meet the moment
,”
said CEO, Carolyn Magill. “As the visibility and value around RWE continues to increase, Priya's expertise will help strengthen Aetion’s position as the standard-bearer
of RWE technology and innovation.”